Literature DB >> 8782661

Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin.

T L Moser1, S V Pizzo, L M Bafetti, D A Fishman, M S Stack.   

Abstract

Epithelial ovarian carcinoma, the leading cause of gynecologic cancer death, is characterized by widespread intra-abdominal metastases mediated primarily by surface shedding of tumor cells and peritoneal implantation. Whereas hematogenous metastasis is known to involve cellular adhesion, extracellular matrix proteolysis and cell migration, the role of these processes in the intraperitoneal dissemination of ovarian cancer remains unclear. To analyze further the role of adhesion and proteolysis in ovarian carcinoma dissemination, we have characterized the adhesive profiles of 4 primary cultures of ovarian carcinoma cells and 5 ovarian carcinoma cell lines. Our data demonstrate preferential adhesion of ovarian carcinoma cells to interstitial type I collagen. Analysis of adhesion molecule expression demonstrated the presence of the alpha2 and beta1 integrin subunits by cell surface ELISA, immunoprecipitation and immunohistochemistry. Furthermore, antibodies directed against the alpha2 and beta1 subunits inhibited adhesion of ovarian carcinoma cells to type I collagen by 56% and 95%, respectively. Plasminogen activator and matrix metalloproteinase production by adherent cells was not altered as a consequence of adhesion to individual extracellular matrix proteins; however, adhesion to an extracellular matrix comprised primarily of interstitial collagen increased plasminogen activator activity in 5 of 5 cell lines. Since the ovarian carcinoma micro-environment is rich in type I collagen, our data suggest that preferential adhesion to type I collagen followed by secretion of serine and metalloproteinases may represent a biochemical mechanism by which the intraperitoneal dissemination of ovarian carcinoma is mediated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782661     DOI: 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.0.CO;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation.

Authors:  M Gonzales; K Haan; S E Baker; M Fitchmun; I Todorov; S Weitzman; J C Jones
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

Review 2.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

Authors:  Juliette O A M van Baal; Cornelis J F van Noorden; Rienk Nieuwland; Koen K Van de Vijver; Auguste Sturk; Willemien J van Driel; Gemma G Kenter; Christianne A R Lok
Journal:  J Histochem Cytochem       Date:  2017-11-22       Impact factor: 2.479

3.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

7.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 8.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

9.  Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Jaclyn Shepard; Angela J Fought; Denise Scholtens; Peter Penzes; Lonnie D Shea; M Sharon Stack
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

10.  Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Angela J Fought; Denise M Scholtens; Lonnie D Shea; M Sharon Stack
Journal:  Lab Invest       Date:  2008-03-24       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.